by synergycap1 | Mar 17, 2017 | Amgen Inc, Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Cholesterol, Drugs (Pharmaceuticals), Economics, Finance, Heart, New England Journal of Medicine, Non-Bank Loans, Repatha (Drug), Statins (Cholesterol-Lowering Drugs), Working Capital
By GINA KOLATA March 17, 2017 The first rigorous test of an expensive new drug that radically lowers cholesterol levels found that it significantly reduced the chance that a high-risk patient would have a heart attack or stroke. These were men and women who...
